Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.6%

2 terminated out of 77 trials

Success Rate

93.1%

+6.5% vs benchmark

Late-Stage Pipeline

8%

6 trials in Phase 3/4

Results Transparency

11%

3 of 27 completed with results

Key Signals

3 with results93% success

Data Visualizations

Phase Distribution

35Total
Not Applicable (22)
P 1 (3)
P 2 (4)
P 3 (3)
P 4 (3)

Trial Status

Completed27
Unknown20
Recruiting19
Not Yet Recruiting5
Withdrawn2
Active Not Recruiting2

Trial Success Rate

93.1%

Benchmark: 86.6%

Based on 27 completed trials

Clinical Trials (77)

Showing 20 of 20 trials
NCT06469801Not ApplicableRecruiting

ECMO ABI Detection With Hyperfine

NCT06095518Completed

DIC Markers and Thrombin Generation Parameters in Patients on ECMO Support: a Pilot Study

NCT07580469Not Yet RecruitingPrimary

Platelets and Extracorporeal Membrane Oxygenation Veno-venous

NCT05566665Active Not Recruiting

Nosocomial Infections in ECMO Patients

NCT05486559Not ApplicableCompletedPrimary

The ECMO-Free Trial

NCT06526533Phase 3RecruitingPrimary

RECOMMEND Platform Trial

NCT05959252Phase 2RecruitingPrimary

BivaLirudin versUS Heparin in Extracorporeal Membrane Oxygenation

NCT05440851Not ApplicableRecruiting

Platform of Randomized Adaptive Clinical Trials in Critical Illness

NCT07156669Not Yet Recruiting

Safety and Performance of the Novalung Ultimate Kit and Xenios 2.0 During Stationary Use in Hospital and Ground-based Transport of Patients on Extracorporeal Life Support (ECLS)

NCT06814340Phase 3Recruiting

"Continuous Positive Airway Pressure on Venovenous extracorporeaL Membrane Oxygenation for Acute respIratory Distress syndrOme"

NCT03948048Recruiting

Study on the Efficacy and Timing of ECMO Therapy in Children With Refractory Septic Shock

NCT04273607Phase 2RecruitingPrimary

Anticoagulation-free VV ECMO for Acute Respiratory Failure

NCT06074406Not ApplicableCompleted

Low-Field Bedside Brain Magnetic Resonance Imaging in Pediatric Extracorporeal Membrane Oxygenation

NCT02851758Not ApplicableRecruitingPrimary

Transplantation of Autologously Derived Mitochondria Following Ischemia

NCT05830721Not ApplicableRecruiting

Continuous Compartment Pressure Monitoring for Compartment Syndrome in VA-ECMO Patients

NCT06750536RecruitingPrimary

Evaluating the Safety and Performance of the MiniLung Petite Kit in Neonatal and Pediatric Patients With Acute Respiratory and Cardiac Failure

NCT05750576Not ApplicableCompleted

Impact of ECMO Cannula Chlorhexidine-impregnated Dressings to Decrease Extracorporeal Membrane Oxygenation-cannula Related Infection Rate

NCT06276010Not ApplicableRecruitingPrimary

Use of Nafamostat Mesilate for Anticoagulation in Patients With ECMO

NCT06275555Not ApplicableRecruitingPrimary

Use of Bivalirudin for Anticoagulation in Patients With Extracorporeal Membrane Oxygenation

NCT05163925RecruitingPrimary

EUROSETS ECMO Study in Clinical Extracorporeal Life Support Applications

Scroll to load more

Research Network

Activity Timeline